Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04981821 · ClinicalTrials.gov registry record · NA

A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms

A NA study of Cancer and Myeloid Neoplasm, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
170
Enrollment target
1
Study location

NCT04981821 is a NA study of Cancer and Myeloid Neoplasm that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 170 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04981821, a NA study of Cancer and Myeloid Neoplasm, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
170 participants
Enrollment target
1
Study location

Study Summary

This is a phase 2 randomized controlled trial (RCT) to assess the preliminary efficacy of the a mobile health exercise intervention (GO-EXCAP) versus a chemotherapy education control in 100 older patients with MN receiving outpatient chemotherapy on physical function and patient-reported outcomes (fatigue, mood, and quality of life). We will also explore the effect of the intervention on TNFα and related cytokine gene promoter methylation and their gene and protein expression.

Conditions Studied

Interventions

  • BEHAVIORAL GO-EXCAP Mobile App
  • BEHAVIORAL Behavioral Placebo Control

Study Locations (1)

New York

  • University of Rochester Medical Center/Wilmot Cancer Institute - Rochester

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2022-01-03
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT04981821

The ClinicalTrials.gov registry entry for NCT04981821 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which GO-EXCAP Mobile App is the first listed.

NCT04981821 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04981821 about?

NCT04981821 is a clinical study titled "A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms". This is a phase 2 randomized controlled trial (RCT) to assess the preliminary efficacy of the a mobile health exercise intervention (GO-EXCAP) versus a chemotherapy education control in 100 older patients with MN receiving outpatient chemotherapy on physical function and patient-reported outcomes (f...

What is the current status of trial NCT04981821?

This trial is currently recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2022-01-03. Estimated completion is 2026-12-31.

What conditions does trial NCT04981821 study?

This clinical trial studies the following conditions: Cancer, Myeloid Neoplasm.

What interventions are being tested in trial NCT04981821?

The interventions under investigation include: GO-EXCAP Mobile App (BEHAVIORAL), Behavioral Placebo Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT04981821?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04981821 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.